Immature double-positive thymocytes are generated in the thymic cortex, and on positive selection, are induced to differentiate into mature single-positive thymocytes and relocate to the medulla. CCR7 is pivotal for cortex-to-medulla migration of positively selected thymocytes, and CCR7-mediated migration to the medulla is essential for establishing central tolerance, thereby, preventing tissue-specific autoimmunity. However, it was unclear how CCR7-mediated migration to the medulla affects the establishment of self-tolerance. Here, we show that the deletion of thymocytes specific for insulin-promoter-driven tissue-restricted antigens (TRAs) is significantly impaired in CCR7-or CCR7-ligand-deficient mice. These results indicate that CCR7-mediated migration to the medulla contributes to the negative selection of TRA-reactive thymocytes.
T
he repertoire of T cells is formed primarily in the thymus. Thymic microenvironments, consisting of various thymic stromal cells, sequentially support the development and selection of thymocytes. In the cortex, cortical thymic epithelial cells (cTECs) present a set of self-peptides, because cTECs express unique proteasomes containing ␤5t (1) and lysosomal proteases (2, 3) , and are autophagous (4) . Immature CD4 ϩ CD8 ϩ [double positive (DP)] thymocytes that express the virgin repertoire of the T cell receptors (TCRs) are generated in the cortex and selected via interaction between the TCRs and the self-peptide/ MHC complexes expressed by cortical cells, including cTECs and hematopoietic cells (5) . DP thymocytes that receive TCRmediated positive-selection signals survive, differentiate into CD4 ϩ CD8 Ϫ [CD4 single positive (CD4SP)] or CD4 Ϫ CD8 ϩ [CD8 single positive (CD8SP)] thymocytes, and relocate to the medulla, where they further interact with the self-peptides displayed in the medullary microenvironments. Medullary thymic ECs (mTECs) express a diverse set of tissue-restricted antigens (TRAs), such as insulin and salivary proteins, which are regulated in part by the nuclear factor Aire (6, 7) and contribute to the deletion of TRA-reactive semimature SP thymocytes (8, 9) . Thymocytes that are reactive to TRAs are also deleted by their interaction with bone marrow-derived antigen-presenting cells, such as dendritic cells (10) . Thus, the stepwise localization of developing thymocytes, initially in the cortex and subsequently in the medulla, appears pivotal in the generation of a diverse, yet self-tolerant, repertoire of T cells. Several chemokines in the thymus have roles in positioning the developing thymocytes (11) . Among these chemokines, the CCR7 ligands (CCR7L: CCL19 and CCL21) regulate the migration of positively selected thymocytes from the cortex to the medulla. When they receive positive-selection-inducing TCR signals, cortical DP thymocytes increase their expression of CCR7 on the cell surface, whereas CCR7L in the thymus is predominantly produced by mTECs and distributed in the medulla (12) . Thymocytes generated in the absence of CCR7 or CCR7L are defective in their accumulation in the medulla and are potent in causing tissue-specific autoimmunity (13) . It has been speculated that CCR7 affects the deletion of TRA-reactive thymocytes in the medulla. However, the mechanism underlying the regulation of central tolerance by CCR7 remains unclear.
Here, we examined the role of CCR7 in the relocation and selection of TRA-reactive thymocytes. The results from three independent lines of CCR7-or CCR7L-deficient mice confirmed that CCR7 guides the migration of both CD4SP and CD8SP thymocytes to the medulla. The analysis of TRA-reactive TCR-transgenic thymocytes showed that CCR7-mediated migration to the medulla contributes to the negative selection of TRA-reactive thymocytes that belong to either CD4SP or CD8SP T cell lineage. We also found that cross-presentation by bone marrow-derived cells acts cooperatively with CCR7-mediated migration to the medulla to eliminate TRA-reactive thymocytes.
Results and Discussion

CCR7 Is Required for the Migration of Positively Selected Thymocytes
to the Medulla. We previously reported the defective migration of SP thymocytes to the medulla in both CCR7L-deficient plt/plt mice and CCR7-deficient mice [here, designated CCR7 Ϫ/Ϫ (ML) (referring to Martin Lipp)] (12, 13). Kwan and Killeen (14) showed that the premature expression of CCR7 results in the aberrant positioning of DP thymocytes in the medulla. These results indicate that CCR7 directs the migration of SP thymocytes to the medulla. However, a recent report by DavalosMisslitz et al. (15) showed that the density of CD4SP thymocytes in the medulla was not reduced in thymus sections of CCR7 Ϫ/Ϫ (ML) mice, thereby questioning the role of CCR7 in the migration of SP thymocytes to the medulla. Accordingly, we reexamined whether CCR7 contributes to the migration of thymocytes to the medulla. In doing so, we included the analysis of a strain of CCR7-deficient mice, which was independently developed and is here designated CCR7 Ϫ/Ϫ (DG) (referring to Deltagen).
First, we reexamined the thymic architecture of these mutant lines lacking either CCR7 or CCR7L. Neither the volume nor the weight of the whole thymus was altered in any of these mice (Table S1 ). Quantitative evaluation of hematoxylin/eosinstained thymus sections showed that the size of the medulla was markedly affected in all of the mice deficient for CCR7 or CCR7L. Most notably, the medullas in all three strains of mice lacking CCR7 or CCR7L were highly enriched in small medullas, whereas the sizes of the medullas in WT thymuses were diversely distributed, from small to large ( Fig. 1 A and B) . These findings are consistent with previous results that showed that the 3D volume of the thymic medulla, but not the thymic cortex, was reduced in mice lacking CCR7 or CCR7L (12) and confirm that CCR7 and CCR7L are required for the optimal development of the thymic medulla.
Recent studies have shown that positively selected thymocytes produce the TNF superfamily ligands, RANKL and CD40L, which foster mTEC proliferation and medulla formation (16, 17) . We found that the expression of RANKL and CD40L by mature SP thymocytes was not diminished in CCR7L-or CCR7-deficient mice (Fig. S1 ), indicating that CCR7-and CCR7L-mediated thymocyte positioning is still required for thymic medulla development, even if SP thymocytes produce RANKL and CD40L.
We next measured the density of CD4SP and CD8SP thymocytes in the thymic medulla. Three individuals in our laboratory carried out independent measurements, including sample-blind trials. We found that the numbers of CD4SP and CD8SP cells per unit area in the medulla, identified by the mTEC-specific antibody ER-TR5, were significantly reduced in the plt/plt mice, CCR7
Ϫ/Ϫ (ML) mice, and CCR7 Ϫ/Ϫ (DG) mice ( Fig. 1 C and D and Fig. S2 ). In all of these mutant strains, the reduction in CD4SP cells (52-63% of the WT number) was smaller than that in the CD8SP cells (9-16% of the WT number). This smallness in reduction might explain why Davalos-Misslitz et al. (15) failed to detect any abnormality in the medullary accumulation of CD4SP thymocytes and may result from the earlier expression of CCR7 in CD8SP-lineage cells than in CD4SP-lineage cells during positive selection (18) . The analysis of TCR-transgenic thymocytes confirmed the contribution of CCR7 to the migration of mature SP thymocytes to the medulla in both CD4SP and CD8SP lineages ( Fig. 2 A and B) . Together, these results indicate that CCR7L and CCR7 are pivotal in the migration of positively selected thymocytes of both the CD4SP and CD8SP lineages to the medulla. We have previously shown that the thymocytes generated in CCR7-or CCR7L-deficient mice are exported from the thymic cortex to the circulation without migration to the medulla and potently induce tissue-specific autoimmunity, indicating that CCR7-mediated thymocyte migration to the thymic medulla is essential in establishing self-tolerance (13) . However, the negative selection of thymocytes reactive to ubiquitously expressed self-antigens was undisturbed in CCR7-or CCR7L-deficient mice (12) , indicating that the TCR-mediated death-inducing signal pathways in thymocytes are intact in mice lacking CCR7 or CCR7L. Therefore, it is possible that CCR7 recruits TRAreactive thymocytes to TRA-expressing mTECs to facilitate negative selection.
To directly examine this possibility, we first analyzed thymocytes that expressed transgenic 3A9-TCR, specific for the hen Fig. S2 ). Graphs show the means and SEs (n ϭ 3). Significant differences from the WT controls are indicated ( * , P Ͻ 0.05; ** , P Ͻ 0.01).
egg lysozyme (HEL) peptide associated with I-A k (19) . The 3A9-TCR high thymocytes were positively selected to be CD4SP and accumulated in the keratin (K)14-positive medullary regions in WT H-2 k mice, but were predominantly arrested in the K14-negative cortical regions of the plt/plt H-2 k thymus (Fig. 3A) ; thus, supporting the proposition that CCR7 is required for the migration of positively selected CD4SP thymocytes to the medulla. The frequency of 3A9-TCR-transgenic CD4SP thymocytes was slightly reduced in the plt/plt H-2 k thymus (Fig. 3B) . In RIP-mHEL-transgenic H-2 k mice, in which membrane-bound HEL is expressed under the control of rat insulin promoter (20) and is consequently produced in a tissue-restricted manner, including in pancreatic ␤-cells and mTECs (Fig. S3) (8) , 3A9-TCR high thymocytes were deleted (Fig. 3A) , most prominently in the mature CD24 low subpopulation of CD4SP thymocytes (Fig.  3 B and C) . Interestingly, however, many 3A9-TCR high thymocytes were detectable in the cortex of the RIP-mHEL plt/plt H-2 k thymus (Fig. 3A) . The frequency of 3A9-TCR high CD24 low mature CD4SP thymocytes was similar between the plt/plt mice in the absence and presence of the RIP-mHEL transgene ( Fig.  3 B and C) . The absolute number of 3A9-TCR high CD24 low mature CD4SP thymocytes was significantly greater in RIPmHEL plt/plt mice than in RIP-mHEL mice (Fig. 3D) . Thus, CCR7L essentially contributes to the migration to the medulla and negative selection of TRA-reactive CD4SP thymocytes. We then analyzed OT-I-TCR-transgenic CD8SP thymocytes, which are specific for the ovalbumin peptide associated with K b and are negatively selected in the thymus of RIP-mOVAtransgenic mice, which express membrane-bound ovalbumin in pancreatic ␤-cells and mTECs (Fig. S3) (9, 10, 21, 22 ). To focus on the role of mTECs and the migration of thymocytes to the medulla without extensive cross-presentation of this antigen by hematopoietic antigen-presenting cells (10) , irradiated mice were reconstituted with bone marrow cells isolated from OT-I-TCR-transgenic ␤ 2 -microgloblin (␤ 2 m)-deficient mice. Positively selected V␣2
high OT-I-TCR-transgenic thymocytes were accumulated in the medullas of WT mice, but were localized in the cortices of plt/plt mice (Fig. 4A) . The V␣2 high CD8SP thymocytes were markedly reduced in the RIP-mOVA thymus (Fig. 4 A-C) , indicating the mTEC-mediated negative selection of positively selected OT-I-TCR-transgenic thymocytes. However, V␣2
high thymocytes in the thymuses of RIP-mOVA plt/plt mice were readily detectable in the cortex and recovered at significantly higher frequencies and absolute numbers than in the thymuses of RIP-mOVA mice (Fig. 4 A-D) . The recovery of V␣2 high CD8SP thymocytes was reproduced in RIP-mOVA mice reconstituted with bone marrow cells from OT-I-TCRtransgenic ␤ 2 m Ϫ/Ϫ CCR7 Ϫ/Ϫ (ML) mice (Fig. 4 B-D) . Together, these results indicate that CCR7 and CCR7L contribute to the migration to the medulla and negative selection of TRA-reactive thymocytes of both the CD4SP and CD8SP lineages.
Hematopoietic Cells Facilitate the Negative Selection of TRA-Reactive
Thymocytes. Although the data discussed above show that the negative selection of TRA-reactive thymocytes is impaired in the absence of CCR7 or CCR7L, 3A9-TCR-transgenic CD4SP T cells in the spleen were deleted similarly in RIP-mHEL plt/plt mice and RIP-mHEL mice (Fig. 3D) . Also, the deletion of OT-I-TCR-transgenic ␤ 2 m-deficient CD8SP T cells in the spleens of RIP-mOVA mice was not significantly restored in the spleens of RIP-mOVA plt/plt mice (Fig. 4E) . Therefore, the TRA-reactive T cells in CCR7L-deficient mice are deleted at the periphery, even though their deletion is impaired in the thymus. These results suggest that TRA-induced negative selection is not solely induced in the thymic medulla via the CCR7-mediated migration of TRA-reactive thymocytes and their interaction with TRA-expressing mTECs. Instead, TRA-specific negative selection may be at least partly achieved by additional mechanisms, which may include the cross-presentation of TRAs by thymic and/or extrathymic antigen-presenting cells.
OT-I-TCR-transgenic thymocytes derived from ␤ 2 msufficient bone marrow cells were subjected to efficient negative selection in the thymuses of RIP-mOVA plt/plt mice, whereas those from ␤ 2 m-deficient bone marrow cells showed impaired negative selection in the RIP-mOVA plt/plt thymus (Fig. 4 C and  D) . Thus, TRA-reactive thymocytes were negatively selected not only by CCR7-dependent thymocyte recruitment to TRAexpressing mTECs, but also by a CCR7-independent mechanism facilitated by bone marrow-derived hematopoietic cells. This CCR7-independent mechanism of negative selection may be mediated by the cross-presentation of TRAs by thymic dendritic cells (10) and/or circulating dendritic cells (23) . Thymic dendritic cells are localized abundantly in the medulla and sparsely in the cortex irrespective of the presence or absence of CCR7 or CCR7L (13) . Thus, it is likely that thymic dendritic cells access TRAs expressed by mTECs, migrate normally between the cortex and the medulla in the thymus, and mediate the negative selection of TRA-reactive thymocytes in the cortex even in the CCR7L-deficient thymus. The low-level transcription of RIPdriven TRAs in other cells, including cTECs (Fig. S3) (10) , and/or the circulation of the TRAs produced (8) , may also contribute to the deletion of TRA-reactive T cells in the thymus and at the periphery. However, the autoimmunity observed in mice lacking CCR7 or CCR7L (13, 24 -26) suggests that the CCR7-independent mechanism of self-tolerance is not thoroughgoing.
Conclusions
Our results confirm that the chemotactic interaction in the thymus between CCR7 expressed by positively selected thymocytes and CCR7L produced by mTECs is essential for the migration of positively selected thymocytes to the medulla and the optimal development of the thymic medulla. We found that CCR7-mediated thymocyte migration to the medulla contributes to the negative selection of TRA-reactive thymocytes, perhaps by facilitating the interaction between positively selected yet TRA-reactive thymocytes and TRA-displaying mTECs (Fig. S4) . Therefore, CCR7-mediated migration to the medulla is pivotal in the establishment of the self-tolerant T cell repertoire by culling the TRA-reactive thymocytes. Additional mechanisms, including cross-presentation by hematopoietic cells, coordinate the CCR7-mediated migration to the medulla for the deletion of TRA-reactive T cells.
Methods
Mice. The plt/plt (27) , CCR7 Ϫ/Ϫ (ML) (28), AND-TCR transgenic (29) , OT-I-TCR transgenic (21), 3A9-TCR transgenic (19) , RIP-mHEL transgenic (20) , RIP-mOVA transgenic (22) , and ␤2m Ϫ/Ϫ mice (30) have been described. The CCR7 Ϫ/Ϫ (DG) mice were developed by Deltagen (http://jaxmice.jax.org/strain/005794.html) and were obtained from The Jackson Laboratory. Experiments were performed with the consent of the Animal Experimentation Committee of the University of Tokushima.
Bone Marrow Chimeras. Bone marrow cells were magnetically depleted of T cells by using biotin-conjugated antibodies specific for CD4, CD8, and Thy1.2 and streptavidin-conjugated magnetic beads (Miltenyi Biotec). Recipient mice were irradiated with X-rays (9.25 Gy) and injected with T cell-depleted bone marrow cells (4 ϫ 10 7 ) 1 day after irradiation. The mice were analyzed 4 -5 weeks after the reconstitution.
Thymus Section Analysis. Frozen thymuses embedded in OCT compound (Sakura Finetek) were sliced into 5-m-thick sections and stained with hematoxylin and eosin. The areas of the cortical and medullary regions were measured by using Image J software. For multicolor confocal analysis, frozen sections were fixed with acetone and stained with the following antibodies: mTEC-specific ER-TR5 antibody followed by Alexa-Fluor-633-conjugated antirat IgG antibody (Molecular Probes), anti-K14 antibody followed by AlexaFluor-633-conjugated anti-rabbit IgG antibody (Molecular Probes), FITCconjugated anti-TCR V␣11 antibody, FITC-conjugated anti-TCR V␣2 antibody, and 3A9-TCR-specific 1G12 antibody followed by FITC-conjugated mouse IgG antibody (Molecular Probes). The images were analyzed with a TSC SP2 confocal laser-scanning microscope and Leica Confocal software version 2.6.
Flow Cytometric Analysis.
Multicolor flow cytometric analysis and cell sorting were performed with FACSCalibur and FACSVantage flow cytometers (BD Biosciences). Thymic stromal cells were prepared by digesting thymus fragments with collagenase, dispase, and DNaseI (Roche), and enriched by depleting the CD45 ϩ cells with a magnetic cell sorter (Miltenyi Biotec) before cell sorting (16) .
Quantitative RT-PCR. Total cellular RNA was reverse-transcribed with oligo(dT) primer and SuperScript III reverse transcriptase (Invitrogen). Real-time RT-PCR was performed by using SYBR Premix Ex Taq (TaKaRa) and a Light Cycler DX400 (Roche). The amplified products were confirmed to be single bands by gel electrophoresis and normalized to the amount of GAPDH amplification products. The primer sequences are available on request.
